CD4 c.203T>G ;(p.F68C)

Variant ID: 12-6909626-T-G

NM_000616.4(CD4):c.203T>G;(p.F68C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


COVID-19 vaccine candidates and vaccine development platforms available worldwide.

Journal Of Pharmaceutical Analysis
Duman, Nilgun N; ALzaidi, Zahraa Z; Aynekin, Busra B; Taskin, Duygu D; Demirors, Busra B; Yildirim, Abdulbaki A; Sahin, Izem Olcay IO; Bilgili, Faik F; Turanli, Eda Tahir ET; Beccari, Tommaso T; Bertelli, Matteo M; Dundar, Munis M
Publication Date: 2021-09-14

Variant appearance in text: CD4: F68C
PubMed Link: 34540318
Variant Present in the following documents:
  • Main text
View BVdb publication page



COVID-19 vaccine candidates and vaccine development platforms available worldwide.

Journal Of Pharmaceutical Analysis
Duman, Nilgun N; ALzaidi, Zahraa Z; Aynekin, Busra B; Taskin, Duygu D; Demirors, Busra B; Yildirim, Abdulbaki A; Sahin, Izem Olcay IO; Bilgili, Faik F; Turanli, Eda Tahir ET; Beccari, Tommaso T; Bertelli, Matteo M; Dundar, Munis M
Publication Date: 2021-12

Variant appearance in text: CD4: F68C
PubMed Link: 34540318
Variant Present in the following documents:
  • Main text
View BVdb publication page



MAIT Cells Balance the Requirements for Immune Tolerance and Anti-Microbial Defense During Pregnancy.

Frontiers In Immunology
Raffetseder, Johanna J; Lindau, Robert R; van der Veen, Sigrid S; Berg, Göran G; Larsson, Marie M; Ernerudh, Jan J
Publication Date: 2021

Variant appearance in text: CD4: F68C
PubMed Link: 34497611
Variant Present in the following documents:
  • Main text
View BVdb publication page